Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Дек. 28, 2024
Abstract
This
study
investigated
the
incidence
of
new-onset
cardiovascular
disorders
up
to
3.5
years
post
SARS-CoV-2
infection
for
56,400
individuals
with
COVID-19
and
1,093,904
contemporary
controls
without
in
Montefiore
Health
System
(03/11/2020
07/01/2023).
Outcomes
were
new
major
adverse
event
(MACE),
arrhythmias,
inflammatory
heart
disease,
thrombosis,
cerebrovascular
disorders,
ischemic
disease
other
cardiac
between
30
days
(up
to)
index
date.
Results
also
compared
a
pre-pandemic
cohort
over
similar
observation
duration
(
N
=
64,541).
Cumulative
hazard
ratios
adjusted
competitive
risks
analyzed.
Compared
controls,
hospitalized
patients
had
significantly
higher
risk
developing
MACE
(aHR
2.29,
95%
confidence
interval
[2.27,
2.31],
p
<
0.001),
arrhythmias
2.54[2.50,
2.58],
5.34[4.79,
5.96],
2.05[2.00,
2.11],
2.31[2.26,
2.35],
thrombosis
4.25[4.15,
4.36],
1.89[1.86,
1.92],
0.001).
Non-hospitalized
slightly
1.04[1.03,
1.06],
1.10[1.08,
1.12],
2.29
[2.03,
2.59],
1.11[1.07,
1.15],
1.13],
Race
ethnicity
mostly
not
associated
increased
>
0.05).
aHRs
as
reference
those
reference.
We
concluded
that
incident
patients,
especially
COVID-19,
than
controls.
Identifying
factors
may
draw
clinical
attention
need
careful
follow-up
at-risk
individuals.
European Journal of Preventive Cardiology,
Год журнала:
2024,
Номер
31(15), С. 1792 - 1803
Опубликована: Июнь 11, 2024
Abstract
Aims
To
assess
whether
implementation
of
the
2019
European
Society
Cardiology
(ESC)/European
Atherosclerosis
(EAS)
dyslipidaemia
guidelines
observed
between
2020
and
2021
improved
2022
in
SANTORINI
study.
Methods
results
Patients
with
high
or
very
cardiovascular
(CV)
risk
were
recruited
across
14
countries
from
March
to
February
2021,
1-year
prospective
follow-up
until
May
2022.
Lipid-lowering
therapy
(LLT)
ESC/EAS
risk-based
low-density
lipoprotein
(LDL)
cholesterol
(LDL-C)
goal
attainment
(defined
as
<1.4
mmol/L
for
patients
at
CV
<1.8
risk)
compared
baseline.
Of
9559
enrolled,
9136
(2626
6504
had
any
available
data,
7210
(2033
5173
baseline
LDL-C
data.
was
escalated
one-third
unchanged
two-thirds.
Monotherapy
combination
usage
rose
53.6
25.6%
57.1
37.9%,
respectively.
Mean
levels
decreased
2.4
2.0
mmol/L.
Goal
21.2
30.9%,
largely
driven
by
LLT
use
among
those
not
on
greater
monotherapy
(39.4
vs.
25.5%).
Conclusion
achievement
lipid
goals
increased
over
particularly
when
used.
Nonetheless,
most
remained
above
goal;
hence,
strategies
are
needed
improve
LLT.
Frontiers in Cardiovascular Medicine,
Год журнала:
2025,
Номер
11
Опубликована: Янв. 14, 2025
The
COVID-19
pandemic,
starting
in
2020,
raised
concerns
about
potential
long-term
health
impacts,
including
its
effects
on
cardiovascular
and
related
biomarkers.
This
study
part
of
the
Bus
Santé
Geneva,
Switzerland,
compared
metabolic
profiles
pre-
(2016-2019)
post-pandemic
(2023-2024)
among
individuals
aged
30-75.
Participants
completed
questionnaires
underwent
a
clinical
visit,
physical
examination
fasting
blood
test
to
assess
lipid
glycemic
profiles.
Linear
regression
was
used
estimate
results
mean
systolic
diastolic
pressure,
cholesterol,
profiles,
after
adjusting
for
age,
sex,
smoking,
socioeconomic
status.
Quantile
models
were
median
values.
A
total
4,558
participants
included.
observed
modest
declines
glucose,
HDL,
LDL
levels
post-pandemic,
with
stable
pressure.
prevalence
treatment
rates
diabetes,
hypertension,
dyslipidemia
remained
consistent.
Unawareness
these
conditions
stable.
Despite
initial
fears
pandemic-induced
debt,
indicate
healthy
likely
driven
by
improved
lifestyle
behaviors.
highlights
importance
monitoring
suggests
that
improvements
may
offset
adverse
pandemic
developed
nations
like
Switzerland.
Stem Cell Research & Therapy,
Год журнала:
2025,
Номер
16(1)
Опубликована: Март 28, 2025
Several
immunosuppressive
therapies
have
been
proposed
as
key
treatment
options
for
critically
ill
patients
since
the
first
appearance
of
severe
acute
respiratory
syndrome
coronavirus
2.
Mesenchymal
stem
cells
(MSCs)
from
different
sources
considered
their
potential
to
attenuate
cytokine
storm
associated
COVID-19
and
consequent
multi-organ
failure,
providing
evidence
safe
efficacious
treatments.
Among
them,
administration
umbilical
cord-derived
MSCs
(UC-MSCs)
has
demonstrated
a
significant
increase
in
survival
rates,
largely
due
potent
properties.
We
applied
next-generation
sequencing
(NGS)
analysis
compare
transcriptomic
profiles
isolated
two
gestational
sources:
amniotic
fluid
(AF)
obtained
during
prenatal
diagnosis
clinically
relevant
cord
counterparts,
which
datasets
were
publicly
available.
A
full
meta-analysis
was
performed
identify
suitable
GEO
NGS
comparison
between
AF-
UC-MSC
samples.
Transcriptome
revelaed
differences
groups,
despite
both
cell
lines
being
strongly
involved
tissue
development,
crucial
achieve
complex
task
wound
healing.
Significantly
enriched
hallmark
genes
suggest
AF-MSC
superior
immunomodulatory
features
against
signaling
pathways
actively
(i.e.,
IL-2/STAT,
TNF-a/NFkB,
IL-2/STAT5,
PI3K/AKT/mTOR).
The
data
presented
here
that
AF-MSCs
hold
promise
treating
not
only
COVID-19-associated
storms
but
also
variety
other
inflammatory
syndromes
those
induced
by
bacterial
infections,
autoimmune
disorders,
therapeutic
interventions).
Realizing
comprehensive
approach
disease
management
will
require
more
extensive
clinical
trials
in-depth
mechanistic
studies.
Journal of the American Heart Association,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 15, 2025
Background
The
COVID‐19
pandemic
saw
a
rise
in
cardiovascular
death,
likely
the
result
of
disruptions
health
care
delivery
and
infection
itself.
We
examine
mortality
trends
heart
failure
(HF)
acute
myocarditis
(AM)
before
during
identify
most
affected
demographic
subgroups.
Methods
Results
queried
Centers
for
Disease
Control
Prevention
Wide‐Ranging
Online
Data
Epidemiologic
Research
database
deaths
from
HF
AM
(1999–2019)
(2020–2021)
pandemic.
Age‐adjusted
rates
were
calculated
stratified
by
sex,
race
ethnicity,
age
category.
Trend‐level
analysis
was
performed
using
Joinpoint
Regression
Program,
which
estimates
average
annual
percentage
change
(AAPC)
age‐adjusted
rate
with
corresponding
95%
CI.
A
total
7
366
944
33
750
occurred
1999
to
2021.
downtrended
(AAPC,
−0.63
−2.42,
respectively)
but
reversed
(HF
AAPC,
7.91;
20.3).
Overall,
pandemic,
both
greater
men,
non‐Hispanic
Black
people,
adults
aged
≥65
years.
sharpest
increase
observed
among
American
Indian
people
14.9),
Hispanic
9.63),
young
20.9)
women
(AAPC
18.7),
15.6),
older
23.5)
AM.
Conclusions
prepandemic
downward
have
since
2020.
Subgroups
that
had
greatest
absolute
years
(aged
years).
Journal of Cardiovascular Emergencies,
Год журнала:
2024,
Номер
10(2), С. 58 - 60
Опубликована: Июнь 1, 2024
Inflammation
is
a
major
factor
in
the
onset
and
progression
of
atherosclerosis,
which
currently
considered
chronic
inflammatory
disease.At
endothelial
level,
inflammation
leads
to
increased
permeability
lipoproteins
their
subendothelial
accumulation,
inducing
dysfunction.The
balance
between
pro-and
anti-inflammatory
properties
determines
atheroma
progression.
1
The
link
long-term
cardiovascular
disease
well-known,
it
has
been
demonstrated
that
can
lead
plaque
vulnerabilization,
triggering
an
acute
coronary
event.Moreover,
systemic
inflammation,
such
as
one
seen
periodontal
or
COVID-19,
correlated
with
atheromatous
progression,
favoring
rupture
thrombosis.
2
Diabetes
mellitus
also
Diseases,
Год журнала:
2024,
Номер
12(7), С. 133 - 133
Опубликована: Июнь 27, 2024
Background:
Patients
with
peripheral
artery
disease
(PAD)
have
40–70%
higher
three-year
mortality
after
lower
limb
amputation
compared
to
non-amputees.
In
this
study,
we
examined
the
consequences
of
delayed
treatment
for
patients
PAD
during
coronavirus
2019
(COVID-19)
pandemic.
Methods:
This
study
employed
a
retrospective
single-centre
cohort
design
at
large
tertiary
care
hospital.
We
amputees
initial
COVID-19
outbreak
period
in
2020
control
group
from
follow-up.
Results:
total,
134
were
included
due
unsuccessful
revascularization
(n
=
84
vs.
n
50
2019).
significantly
younger
than
those
(p
0.01)
and
mostly
admitted
advanced
stages
<
0.03).
The
proportion
major
amputations
increased
Non-COVID-19-related
deaths
among
more
twice
as
many
2019,
long-term
was
49%
39%
0.04).
Diabetes
renal
insufficiency
had
negative
impact
on
survival
0.01).
Conclusions:
Delayed
leads
high
risk
amputation,
especially
diabetes
insufficiency.
Therefore,
future
pandemics,
continuously
monitoring
will
be
crucial
prevent
severe
short-term
consequences.
Abstract
With
technological
advancements,
much
data
is
being
captured
by
sensors,
smartphones,
wearable
devices,
and
so
forth.
These
vast
datasets
are
stored
in
centres
utilized
to
forge
data‐driven
models
for
the
condition
monitoring
of
infrastructures
systems
through
future
mining
tasks.
However,
these
often
surpass
processing
capabilities
traditional
information
methodologies
due
their
significant
size.
Additionally,
not
all
samples
within
contribute
valuable
during
model
training
phase,
leading
inefficiencies.
The
Machine
Learning
algorithms
become
time‐consuming,
storing
demands
excessive
space,
contributing
Big
Data
challenge.
In
this
paper,
we
propose
two
novel
techniques
reduce
large
time‐series
into
more
compact
versions
without
undermining
predictive
performance
resulting
models.
methods
also
aim
decrease
time
required
storage
space
needed
condensed
datasets.
We
evaluated
our
on
five
public
datasets,
employing
three
algorithms:
Holt‐Winters,
SARIMA,
LSTM.
outcomes
indicate
that
most
examined,
maintain,
several
instances
enhance,
forecasting
accuracy
Moreover,
significantly
reduced
train
employed.
PLOS Global Public Health,
Год журнала:
2024,
Номер
4(9), С. e0003411 - e0003411
Опубликована: Сен. 10, 2024
While
SARS-CoV-2
infection
appears
to
have
spread
widely
throughout
Africa,
documentation
of
associated
mortality
is
limited.
We
implemented
a
representative
serosurvey
in
one
city
Sierra
Leone
Western
paired
with
nationally
and
selected
death
registration
data.
Cumulative
seroincidence
using
high
quality
serological
assays
was
69%
by
July
2021,
rising
84%
April
2022,
mostly
preceding
vaccination.
About
half
infections
showed
evidence
neutralizing
antibodies.
However,
excess
rates
were
low,
concentrated
at
older
ages.
During
the
peak
weeks
viral
activity,
22%
for
individuals
aged
30–69
years
70%
those
over
70.
Based
on
electronic
verbal
autopsy
dual
independent
physician
assignment
causes,
deaths
during
peaks
from
respiratory
notable.
Excess
differed
little
across
specific
causes
that,
priori,
are
COVID,
pattern
consistent
among
adults
or
without
chronic
disease
risk
factors.
The
overall
6%
ages
≥30
2020–2022
markedly
lower
than
reported
South
India,
Latin
America.
Thus,
while
widespread,
our
study
highlights
as
yet
unidentified
mechanisms
heterogeneity
susceptibility
severe
parts
Africa.
International Journal of Epidemiology,
Год журнала:
2024,
Номер
54(1)
Опубликована: Дек. 16, 2024
Abstract
Background
During
the
COVID-19
pandemic,
mortality
from
some
chronic
diseases
increased.
In
this
study,
we
evaluated
monthly
excess
all
causes,
cancer,
cardiovascular
(CVD)
and
diabetes
during
months
of
2020
2021,
examining
its
relationship
with
cases.
Methods
Monthly
cause-specific
data
were
downloaded
public
repositories
national
statistics
offices
or
directly
requested
them,
population
obtained
United
Nations
archives.
Excess
deaths
estimated
as
difference
between
observed
expected
deaths.
for
2021
calculated
using
a
quasi-Poisson
regression
model
trained
on
2010–19
(or
shorter
timespan
if
full
decade
was
not
available).
To
quantify
correlation
cases
mortality,
used
Spearman’s
coefficient
(rs).
Results
The
study
included
16
countries
that
provided
causes
death
(Argentina,
Austria,
Brazil,
Switzerland,
Chile,
Czech
Republic,
Germany,
Georgia,
Hungary,
Italy,
Lithuania,
Latvia,
Mexico,
Serbia,
Slovakia
USA).
A
positive
found
in
(rs
ranging
0.61
to
0.91),
CVD
11
0.45
0.85)
13
0.42
0.79).
above
5%
14
both
seven
nine
12
2021.
No
cancer
any
considered.
Conclusions
persisted
several
throughout
These
increases
coincide
peaks,
supporting
short-term
impact
pandemic
these
causes.